130 results
Page 3 of 7
8-K/A
EX-99.1
fw3c 1ofke6awai
23 Nov 20
Consolidated Financial Statements
12:00am
424B7
q9vexg7bdag1za
5 Nov 20
Prospectus with selling stockholder info
5:27pm
8-K
EX-10.3
7puzasini lsi3
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
u5ie 5nusb
28 Aug 20
Prospectus supplement
4:31pm
425
w0sqe 35qti1h
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-10.1
sdlcdu
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.3
wtj14wei11xpnd8i6wr
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
19pbrxl16royjhswifx
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
S-3ASR
onjox3o1
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
08u22xivzcbmc9q7
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-1.1
86cxa
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm